ArticleMolecular and cellular biology1995
Constitutive repression and nuclear factor I-dependent hormone activation of the mouse mammary tumor virus promoter in Saccharomyces cerevisiae.
Article in Molecular and cellular biology, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 44 citations in OpenAlex.
- Erk signaling and chromatin remodeling in MMTV promoter activation by progestins.Nuclear receptor signaling · 2009Review
- Recruitment of a chromatin remodelling complex by the Hog1 MAP kinase to stress genes.The EMBO journal · 2009Article
- Yeast genetic analysis reveals the involvement of chromatin reassembly factors in repressing HIV-1 basal transcription.PLoS genetics · 2009Article
- An improved system for estradiol-dependent regulation of gene expression in yeast.Microbial cell factories · 2007Article
- A gene-specific requirement for FACT during transcription is related to the chromatin organization of the transcribed region.Molecular and cellular biology · 2006Article
- Partial depletion of histone H4 increases homologous recombination-mediated genetic instability.Molecular and cellular biology · 2005Article
- Transcriptionally competent chromatin assembled with exogenous histones in a yeast whole cell extract.Nucleic acids research · 2004Article
- The absence of the yeast chromatin assembly factor Asf1 increases genomic instability and sister chromatid exchange.EMBO reports · 2004Article
- Histone H1 enhances synergistic activation of the MMTV promoter in chromatin.The EMBO journal · 2003Article
- Hpr1 is preferentially required for transcription of either long or G+C-rich DNA sequences in Saccharomyces cerevisiae.Molecular and cellular biology · 2001Article
- Histone acetyltransferase complexes can mediate transcriptional activation by the major glucocorticoid receptor activation domain.Molecular and cellular biology · 1999Article
- Chromatin structure of the simian virus 40 late promoter: a deletional analysis.Journal of virology · 1999Article
- Assembly of MMTV promoter minichromosomes with positioned nucleosomes precludes NF1 access but not restriction enzyme cleavage.Nucleic acids research · 1998Article
- Binding of NF1 to the MMTV promoter in nucleosomes: influence of rotational phasing, translational positioning and histone H1.Nucleic acids research · 1997Article
- Role of the Ada adaptor complex in gene activation by the glucocorticoid receptor.Molecular and cellular biology · 1997Article
- Nucleosome-mediated synergism between transcription factors on the mouse mammary tumor virus promoter.Proceedings of the National Academy of Sciences of the United States of America · 1997Article
- Moderate increase in histone acetylation activates the mouse mammary tumor virus promoter and remodels its nucleosome structure.Proceedings of the National Academy of Sciences of the United States of America · 1996Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To study the influence of various transactivators and the role of nucleosomal structure in gene regulation by steroid hormones, we have introduced mouse mammary tumor virus (MMTV) promoter sequences along with expression vectors for the glucocorticoid receptor (GR) and nuclear factor I (NFI) in Saccharomyces cerevisiae, an organism amenable to genetic manipulation. Both in the context of an episomal multicopy vector and in a centromeric single-copy plasmid, the MMTV promoter was virtually silent in the absence of inducer, even in yeast strains expressing GR and NFI. Induction was optimal with deacylcortivazol and required both GR and NFI. The transactivation function AF1 in the N-terminal half of GR is required for ligand-dependent induction and acts constitutively in truncated GR lacking the ligand binding domain. A piece of the MMTV long terminal repeat extending from -236 to +111 is sufficient to position a nucleosome, B, over the regulatory region of the promoter from -45 to -190 and another nucleosome over the transcription start region. The rotational orientation of the DNA on the surface of nucleosome B is the same as that previously found in animal cells and in reconstitution experiments. This orientation is compatible with binding of GR to two sites, while it should preclude binding of NFI and hence be responsible for constitutive repression. Upon ligand induction, there is no major chromatin rearrangement, but the proximal linker DNA, including the TATA box, becomes hypersensitive to nucleases. The transcriptional behavior of the MMTV promoter was unaffected by deletions of the genes for zuotin or SIN1/SPT2, two proteins which have been claimed to assume some of the functions of linker histones. Thus, despite the lack of histone H1, yeast cells could be a suitable system to study the contribution of nucleosomal organization to the regulated expression of the MMTV promoter.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.